Lipocalin 2 is present in the EAE brain and is modulated by natalizumab

Lipocalin 2 is present in the EAE brain and is modulated by natalizumab

Multiple sclerosis is a demyelinating disease that causes major neurological disability in young adults. A definitive diagnosis at the time of the first episode is still lacking, but since early treatment leads to better prognosis, the search for early biomarkers is needed. Here we characterized the...

Full description

Bibliographic Details
Main Authors: Fernanda eMarques, Sandro D Mesquita, Joao C Sousa, Giovanni eCoppola, Fuying eGao, Daniel H Geschwind, Sandra eColumba-cabezas, Francesca eAloisi, Matilda eDegna, João J Cerqueira, Nuno eSousa, Margarida eCorreia-Neves, Joana A Palha
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-08-01
Series:Frontiers in Cellular Neuroscience
Subjects:
Astrocytes
Cerebrospinal Fluid
Multiple Sclerosis
Experimental autoimmune encephalomyelitis
lipocalin 2
natalizumab
Online Access:http://journal.frontiersin.org/Journal/10.3389/fncel.2012.00033/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fncel.2012.00033/full

Similar Items